Skip to main content

Industry and engagement

Working together to achieve innovations in drug development
We work closely with industry partners and training programs to take breakthrough discoveries to the next stage.
Variety of drug tablets, pills and capsules

Our collaborative research and training projects

The NSW Health PhD Partnership Program

Our researchers have collaborative projects with several biomedical and pharmaceutical companies, supported by PhD scholarships from NSW Health. If you are interested in working with us, please get in touch to find out more.

Learn more about the NSW Health PhD Partnership Program.

The ARC Centre for Fragment-based Design

The ARC CFBD is a multidisciplinary collaboration of researchers from Monash University, the Drug Discovery Initiative, and Griffith University. The Centre provide state-of-the-art training for HDR students, with transformative research programs to build partnerships between university-based researchers and industry-based research end-users.

Learn more aboiut the ARC Centre for Fragment-based Design.


The DDI is proud to have hosted the 2020/21 SPARK Sydney program in collaboration with the Faculty of Medicine and Health. SPARK is a translational research and education program that provides training, mentorship, and milestone funding to research teams working in early stage drug development.

Four teams, led by Dr Nicholas HuntDr Pegah Varamini, Dr Michael Morris and Dr Shiyang Jia participated. Over 12 months, the program provided education, mentorship and funding necessary to advance their research discoveries. Teams were matched with industry experts and personnel with experience that addressed knowledge gaps in their team. Participants attended workshops and regular milestone meetings, with each team receiving $15,000 of seed funding to support their translational journey.

Dr Pegah Varamini is wearing a white coat and holding a test tube

“Being a SPARK participant was a fantastic experience. The knowledge I gained regarding all aspects of drug development and the commercialisation pathway is priceless,” said Dr Pegah Varamini (pictured left), 2020/21 SPARK Sydney team leader.

Find out more about the program here.

Pre-IP Guidance Forums

In partnership with MTPConnect, the DDI recently hosted the first Pre-IP forum, where an expert panel of industry representatives and venture capitalists gave feedback and guidance on DDI Members’ Pre-IP research projects across our five disease focus areas.

Read more about this event and future forums here.  

Academic and industry partner in discussion

Our outreach activities

We are always looking to engage with anyone interested in early stage drug development. We run events throughout the year for researchers, medical professionals, industry representatives and the general public.

Find out more about past and upcoming events here.